Turk Kardiyol Dern Ars. Ahead of Print: TKDA-60094 | DOI: 10.5543/tkda.2017.60094
Assessment of the Association Between serum Uric Acid level and the Predicted Risk Score of Sudden Cardiac Death at Five Years in Patients with Hypertrophic Cardiomyopathy
, Muhammet Hulusi Satılmışoğlu1
, Mehmet Gül1
, Huseyin Uyarel2
, Osman Akin Serdar31
1Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Department of Cardiology, Istanbul, Turkey2
Bezmialem Vakıf University, Faculty of Medicine, Department of Cardiology, Istanbul, Turkey3
Uludag University, Faculty of Medicine, Bursa, Turkey, Department of Cardiology
OBJECTIVE The aim of this study was to determine the relationship between serum uric acid(UA) level and the predicted risk score of sudden cardiac death in five years(the HCM risk-SCD), galectin-3 level, and positive fragmented QRS(fQRS) on electrocardiography(ECG) in patients with hypertrophic cardiomyopathy(HCM).
METHODS This was a prospective observational study. One hundred and fifteen consecutive patients(age>17years) with HCM and 80 healthy subjects were included in the study. The HCM risk-SCD score(%), galectin-3 level, and fQRS were evaluated on ECG in all patients.
RESULTS Serum UA, galectin-3 level, UA/Creatinine(Cr), incidence of ventricular tachycardia(VT) and syncope, some echocardiographic parameters were significantly higher in the patient group than in the control group(all p<0.05). Uric acid value was significantly higher in patients with high score of the HCM Risk-SCD, positive fQRS, high galectin-3 level, VT incidence, requirement of implantable cardioverter defibrillator(ICD) implantation, CPR(cardiopulmonary resuscitation) than in those without(HCM Risk-SCD>6%, UA: 6.71±1.29mg/dl, HCM Risk-SCD≤5.9%, UA: 5.84±1.39mg/dl, p=0.001; fQRS(+), UA: 6.56±1.20mg/dl, fQRS(-), UA: 5.63±1.49mg/dl, p<0.001; galectin-3>6.320pg/ml, UA: 6.56±1.27mg/dl, galectin-3≤6.310pg/ml, p=0.016; left atrium anterior-posterior dimension(LAAPD)>36mm, UA: 6.31±1.33mg/dl, LAAPD<36mm, UA: 5.20±1.60mg/dl, p=0.005; ventricular tachycardia(VT)(+), UA: 6.83±1.19mg/dl, VT(-), UA: 5.97±1.42mg/dl, p=0.008; ICD(+), UA: 7.08±0.88mg/dl, ICD(-), UA: 6.06±1.42mg/dl, p=0.022; CPR(+), UA: 7.03±0.96mg/dl, CPR(-), UA: 6.04±1.42mg/dl, p=0.018). A statistically significant correlation was observed between UA and HCM Risk-SCD, galectin-3 level, LAAPD, LVM(respectively r and p values: 0.355; <0.001, 0.297; 0.002, 0.309; 0.001, 0.276; 0.003).
CONCLUSION Serum UA level was significantly higher in patients with HCM compared to the control group. High UA level was associated with higher the HCM risk-SCD score, positive fQRS, galectin-3 levels, LAAPD, VT incidence, requirement for ICD implantation and CPR in patients with HCM.
Uric acid, cardiomyopathy, hypertrophic, sudden cardiac death, risk
How to cite this article
Corresponding Author: Sinem Özyılmaz, Türkiye